BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1716903)

  • 1. T-cell recognition of myelin basic protein.
    Wucherpfennig KW; Weiner HL; Hafler DA
    Immunol Today; 1991 Aug; 12(8):277-82. PubMed ID: 1716903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoreactive T cells in multiple sclerosis.
    Zhang J; Weiner HL; Hafler DA
    Int Rev Immunol; 1992; 9(3):183-201. PubMed ID: 1285060
    [No Abstract]   [Full Text] [Related]  

  • 3. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
    Ota K; Matsui M; Milford EL; Mackin GA; Weiner HL; Hafler DA
    Nature; 1990 Jul; 346(6280):183-7. PubMed ID: 1694970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic immunomodulation in neurology: from hope to reality. Exemplified by multiple sclerosis].
    Schluep M; Regli F
    Praxis (Bern 1994); 1995 Sep; 84(38):1021-4. PubMed ID: 7481299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathogenic mechanisms in experimental allergic encephalomyelitis.
    Kálmán B; Lublin FD
    Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):182-8. PubMed ID: 7683223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis.
    Salvetti M; Ristori G; D'Amato M; Buttinelli C; Falcone M; Fieschi C; Wekerle H; Pozzilli C
    Eur J Immunol; 1993 Jun; 23(6):1232-9. PubMed ID: 7684682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial toxin superantigens activate human T lymphocytes reactive with myelin autoantigens.
    Burns J; Littlefield K; Gill J; Trotter JL
    Ann Neurol; 1992 Sep; 32(3):352-7. PubMed ID: 1384422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infection and multiple sclerosis].
    Yamamura T
    Rinsho Shinkeigaku; 1999 Jan; 39(1):24-5. PubMed ID: 10377791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell vaccination in multiple sclerosis: immunoregulatory mechanism and prospects for therapy.
    Zhang J
    Crit Rev Immunol; 2001; 21(1-3):41-55. PubMed ID: 11642613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin basic protein peptide specificity and T-cell receptor gene usage of HPRT mutant T-cell clones in patients with multiple sclerosis.
    Lodge PA; Allegretta M; Steinman L; Sriram S
    Ann Neurol; 1994 Nov; 36(5):734-40. PubMed ID: 7526775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.
    Olsson T; Zhi WW; Höjeberg B; Kostulas V; Jiang YP; Anderson G; Ekre HP; Link H
    J Clin Invest; 1990 Sep; 86(3):981-5. PubMed ID: 1697609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimolecular interactions in experimental autoimmune demyelinating disease and prospects for immunotherapy.
    Bell RB; Steinman L
    Semin Immunol; 1991 Jul; 3(4):237-45. PubMed ID: 1718484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The T-cell response to myelin basic protein in familial multiple sclerosis: diversity of fine specificity, restricting elements, and T-cell receptor usage.
    Joshi N; Usuku K; Hauser SL
    Ann Neurol; 1993 Sep; 34(3):385-93. PubMed ID: 7689820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis.
    Brabb T; Goldrath AW; von Dassow P; Paez A; Liggitt HD; Goverman J
    J Immunol; 1997 Jul; 159(1):497-507. PubMed ID: 9200491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of the T-cell receptor beta gene rearrangements generated in myelin basic protein-specific T-cell clones isolated from a patient with multiple sclerosis.
    Richert JR; Robinson ED; Johnson AH; Bergman CA; Dragovic LJ; Reinsmoen NL; Hurley CK
    Ann Neurol; 1991 Mar; 29(3):299-306. PubMed ID: 1710434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MS: a localized immune disease of the central nervous system.
    Calder V; Owen S; Watson C; Feldmann M; Davison A
    Immunol Today; 1989 Mar; 10(3):99-103. PubMed ID: 2472812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis.
    Zamvil SS; Mitchell DJ; Moore AC; Kitamura K; Steinman L; Rothbard JB
    Nature; 1986 Nov 20-26; 324(6094):258-60. PubMed ID: 2431317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis.
    Utz U; Biddison WE; McFarland HF; McFarlin DE; Flerlage M; Martin R
    Nature; 1993 Jul; 364(6434):243-7. PubMed ID: 7686632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.